BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response. Pharmacol Res 2022;:106311. [PMID: 35716914 DOI: 10.1016/j.phrs.2022.106311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bin Y, Deng W, Hu H, Zeng Q, Chen J, Xu Y, Dai Y, Liao A, Xiao W. RASSF1A inhibits epithelial–mesenchymal transition of gastric cancer cells by downregulating P‐JNK. Cell Biology International 2022. [DOI: 10.1002/cbin.11958] [Reference Citation Analysis]
2 Zhou X, Liu T, Deng S, Zhang T, Wu D, Xu Y. PAMR1 is a favorable diagnostic and prognostic biomarker in hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2114251/v1] [Reference Citation Analysis]
3 Fu Z, Zhu G, Luo C, Chen Z, Dou Z, Chen Y, Zhong C, Su S, Liu F. Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment. Front Oncol 2022;12:971462. [DOI: 10.3389/fonc.2022.971462] [Reference Citation Analysis]